User profiles for PJ Ross

Pablo Juan Ross

- Verified email at ucdavis.edu - Cited by 5735

P Joel Ross

- Verified email at upei.ca - Cited by 3170

[HTML][HTML] Immunity to the respiratory pathogen Bordetella pertussis

R Higgs, SC Higgins, PJ Ross, KHG Mills - Mucosal immunology, 2012 - Elsevier
Bordetella pertussis causes whooping cough, a severe respiratory tract infection in infants
and children, and also infects adults. Studies in murine models have shown that innate …

Recent advances in bovine in vitro embryo production: reproductive biotechnology history and methods

…, LB Strøbech, P Hyttel, P Mermillod, PJ Ross - Animal, 2020 - cambridge.org
In vitro production (IVP) of embryos and associated technologies in cattle have shown significant
progress in recent years, in part driven by a better understanding of the full potential of …

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 …

…, O Rosmorduc, V Breder, R Gerolami, G Masi, PJ Ross… - The Lancet, 2017 - thelancet.com
Background There are no systemic treatments for patients with hepatocellular carcinoma (HCC)
whose disease progresses during sorafenib treatment. We aimed to assess the efficacy …

[HTML][HTML] Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre …

…, JR Izbicki, GW Middleton, S Cummins, PJ Ross… - The Lancet, 2017 - thelancet.com
Background The ESPAC-3 trial showed that adjuvant gemcitabine is the standard of care
based on similar survival to and less toxicity than adjuvant 5-fluorouracil/folinic acid in patients …

The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response

…, V Pétrilli, AK Zaiss, LR White, SA Clark, PJ Ross… - Nature, 2008 - nature.com
The innate immune system recognizes nucleic acids during infection and tissue damage.
Whereas viral RNA is detected by endosomal toll-like receptors (TLR3, TLR7, TLR8) and …

[HTML][HTML] Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled …

A Lamarca, DH Palmer, HS Wasan, PJ Ross… - The Lancet …, 2021 - thelancet.com
Background Advanced biliary tract cancer has a poor prognosis. Cisplatin and gemcitabine
is the standard first-line chemotherapy regimen, but no robust evidence is available for …

DNA methylation in embryo development: epigenetic impact of ART (assisted reproductive technologies)

S Canovas, PJ Ross, G Kelsey, P Coy - Bioessays, 2017 - Wiley Online Library
DNA methylation can be considered a component of epigenetic memory with a critical role
during embryo development, and which undergoes dramatic reprogramming after fertilization. …

SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma

AX Zhu, O Rosmorduc, TR Evans, PJ Ross… - … , vol. 33, num. 6, p. 559 …, 2014 - diposit.ub.edu
PURPOSE: To compare the clinical outcomes of sorafenib plus either erlotinib or placebo in
patients with advanced hepatocellular carcinoma (HCC) in a multicenter, multinational, …

[HTML][HTML] Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?

PJ Ross, S Ashley, A Norton, K Priest, JS Waters… - British journal of …, 2004 - nature.com
To examine whether weight loss at presentation influences outcome in patients who received
chemotherapy for lung cancer or mesothelioma. Multivariate analysis of prospectively …

Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer—pooled analysis from three multicenter, randomized, controlled …

…, JS Waters, J Oates, PJ Ross - Journal of clinical …, 2004 - ascopubs.org
Purpose To identify baseline prognostic factors and assess whether pretreatment quality of
life (QoL) predicts survival in patients with locally advanced or metastatic esophago-gastric …